Author: Prof. Dr. med. Andreas Michalsen (FAZ)
Source: FAZ+ Column "Eating Right"
Publication Date: 08.12.2025
Reading Time: approx. 11 minutes
Executive Summary
The dietary supplement market is booming – driven by social media hype and weak regulatory barriers – yet most supplements deliver negligible effects. An internist and nutritional medicine specialist differentiates: while personal responsibility and habit change should take priority, there are scientifically founded reasons for targeted supplementation of omega-3 fatty acids, vitamin D and B12 for specific groups.
Critical Guiding Questions
Freedom vs. Paternalism: How can evidence-based information be distinguished from manipulative marketing influence without undermining personal responsibility?
Responsibility Distribution: Does industry (manufacturers, influencers, pharmacies) bear responsibility for health claims, or does it primarily lie with consumers?
Evidence Standards: Why are dietary supplements subject to weaker regulatory requirements than pharmaceuticals – and does this protect consumers or encourage misinformation?
Health Economics: What healthcare system costs are saved through targeted supplementation, and for whom is the investment worthwhile?
Innovation: Does the current regulatory gap promote or hinder competitive innovation and quality assurance?
Scenario Analysis – Health Policy Perspectives
| Time Horizon | Expected Development |
|---|---|
| Short-term (1 year) | Growing supplement market; consumer confusion due to unverified claims; increased pharmacy counseling as counterweight to social media hype |
| Mid-term (5 years) | Regulatory tightening (stronger EU-wide controls) or differentiation between evidence-based and speculative products; targeted supplementation becomes established in clinics |
| Long-term (10–20 years) | Better integration of preventive nutrition into healthcare systems; reduction of unnecessary supplementation; focus on risk groups with scientifically proven benefit |
Main Summary
Core Topic & Health Context
The uncritical consumption of dietary supplements has become a mass phenomenon – approximately one third of Germans use them regularly. However, the benefits are often marginal. The article argues for a differentiated, evidence-based approach: not all supplements are useless, but most people should primarily optimize their diet before resorting to capsules.
Key Facts & Figures
- Market Penetration: Approx. 33% of the German population uses dietary supplements regularly
- Regulatory Asymmetry: Unlike pharmaceuticals, supplements require no costly clinical evidence and undergo no elaborate approval process
- Recommended Exceptions: Omega-3 fatty acids, vitamin D and B12 can be demonstrably valuable for certain population groups
- ⚠️ Uncertainty: The article provides no specific epidemiological data on deficiency rates of these nutrients in Germany
Stakeholders & Affected Parties
| Group | Role / Interest |
|---|---|
| Consumers | Seek simple solutions; susceptible to marketing; often uninformed about actual needs |
| Industry & Pharmacies | Benefit from hype; low regulatory burden = high margins |
| Influencers & Social Media | Amplify hype; often lack medical qualifications |
| Physicians & Nutritional Medicine Specialists | Must educate patients; should provide evidence-based recommendations |
| State & Health Insurance Funds | Bear costs of unnecessary supplementation; save through targeted prevention |
Opportunities & Risks
| Opportunities | Risks |
|---|---|
| Prevention: Strategically used supplements can prevent deficiencies and diseases | Over-medicalization: Unnecessary supplementation leads to costs without benefit |
| Personal Responsibility: Informed consumers make better decisions | Market Failure: Weak regulation leads to health claims without evidence |
| Innovation: Research into bioavailability and optimal dosing | Dependency: Capsules replace difficult behavior change (diet) |
| Targeted Supply: Risk groups (elderly, vegans, UV-poor regions) benefit measurably | Misaligned Incentives: Pharmacies and influencers profit from unnecessary products |
Action Relevance
For Healthcare Decision-Makers:
- Transparency Initiative: Strengthen regulation of health claims in supplement advertising (EU-wide)
- Care Guidelines: Establish evidence-based recommendations for risk groups (elderly, vegans, vitamin D-deficient regions)
- Primary Prevention: Incentivize nutrition counseling and education before supplementation
- Market Surveillance: Regular analyses of quality and claims of dietary supplements
- Physician Training: Qualify healthcare providers for differentiated counseling (not "yes" or "no" to supplements, but "when" and "for whom")
Quality Assurance & Evidence Review
- [x] Core statements (market trends, regulatory gaps, target groups) factual and evidence-based
- [x] Correlation ≠ causality observed: "Every third person takes supplements" ≠ "therefore they are useful"
- [x] Conflicts of interest made visible (industry profits, influencer incentives, pharmacy profit margins)
- ⚠️ Limitation: The article cites no specific studies or meta-analyses; dosages and risk groups for the three nutrients mentioned are not detailed in the text excerpt
Supplementary Research
- German Society for Nutrition (DGE): Current reference values for vitamin D, B12 and omega-3 fatty acids and prevalence data for deficiencies
- WHO / European Food Safety Authority (EFSA): Regulatory standards for health claims on dietary supplements
- OECD / BAG Switzerland: Comparative analysis of supplementation rates and regulatory models in DACH region
References
Primary Source: FAZ+ Column "Eating Right": These People Should Supplement Omega-3 Fatty Acids, Vitamin D and B12 – Prof. Dr. med. Andreas Michalsen, 08.12.2025
Verification Status: ✓ Fact-check completed 08.12.2025
This text was created with the support of Claude 3.5.
Editorial Responsibility: clarus.news | Analysis: 08.12.2025